<DOC>
	<DOCNO>NCT00785928</DOCNO>
	<brief_summary>To assess efficacy LY2127399 versus placebo use ACR50 response scale 24 week</brief_summary>
	<brief_title>A Study Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Have give write informed consent Women must risk become pregnant study participation Diagnosis Rheumatoid Arthritis Current , regular use Methotrexate , stable dose Other criterion review study doctor Use exclude medication ( review study doctor ) Have fail biologic TNFa inhibitor therapy Have recent ongoing infection , opinion study doctor put patient unacceptable risk participation study Evidence tuberculosis Have systemic inflammatory condition RA , juvenile RA , Crohn 's disease , ulcerative colitis , psoriatic arthritis seronegative spondyloarthropathy Other criterion review study doctor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Arthritis</keyword>
</DOC>